FDA grants priority review to Roche’s risdiplam for spinal muscular atrophy

NEXT STORY
Curetis Publishes Third Quarter and 9-Month Business and Financial Update
PREV STORY
Novartis to acquire The Medicines Company for USD 9.7 bn, adding inclisiran, a potentially transformational investigational cholesterol-lowering therapy to address leading global cause of death
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Chembio Diagnostics Awarded $12.7 Million by BARDA for Development of Rapid DPP Respiratory Antigen Panel and 510(k) Submission of the Rapid DPP SARS-CoV-2 Antigen Test System

author_avatar
NASDAQ Market News

FIT Biotech Oy: FIT Biotech Receives EUR 644,868 Payment from European HIV Vaccine Alliance (EHVA)

FIT Biotech Oy  Company release 12 July, 2017 at 4:00 PM EET FIT Biotech ...

author_avatar
NASDAQ Market News

Progenics Announces Preliminary Voting Results of Annual Meeting of Shareholders

author_avatar
NASDAQ Market News